ClinicalTrials.Veeva

Menu

To Assess the Utility of the Point Mini in a Clinical Take-home Study

P

Point Designs

Status

Enrolling

Conditions

Amputation, Congenital
Amputation; Traumatic, Hand

Treatments

Device: Point Mini

Study type

Interventional

Funder types

Other
Industry
NIH

Identifiers

NCT06501092
445970
4R44HD113485-02 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The objective of this study is to evaluate the efficacy of the Point Mini system as compared to the subject's existing prosthetic treatment, which may include a prosthesis, other assistive device, or no device. This study will be a single subject crossover design where one group of 14 children with partial hand deficiencies will be evaluated on several metrics using their existing prosthetic treatment for one month and the Point Mini system for two months. Metrics include: in-clinic functional measures, subjective assessments, bilateral hand use, and prosthesis wear time.

Enrollment

14 estimated patients

Sex

All

Ages

5 to 15 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Partial hand loss with at least index and/or middle finger loss at the metacarpophalangeal (MCP) level
  • Intact thumb with full range of motion
  • Fluent in English
  • Age between 5 and 15 years

Exclusion criteria

  • Patients with a residual limb that is unhealed from the amputation surgery
  • Unhealed wounds
  • Significant cognitive deficits as determined upon clinical evaluation
  • Significant neurological deficits as determined upon clinical evaluation
  • Significant physical deficits of the residual limb impacting full participation in the study as determined upon clinical evaluation
  • Uncontrolled pain or phantom pain impacting full participation in the study as determined upon clinical evaluation
  • Serious uncontrolled medical problems as judged by the project therapist

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

14 participants in 2 patient groups

Current/No Device
No Intervention group
Description:
Baseline outcome measurements will be performed with subject's existing partial hand prosthetic treatment, as deemed standard-of-care by the patient's prosthetist. Device types include, but are not limited to, no prosthesis, passive prosthesis, passive positional prosthesis, body-powered prosthesis, myoelectric prosthesis, or other assistive device.
Point Mini
Experimental group
Description:
Outcome measurements will be performed after the subject has been fit with a prosthesis at 3 different points in time: immediately post-fitting, \~30 days post-fitting, and \~60 days post-fitting.
Treatment:
Device: Point Mini

Trial contacts and locations

2

Loading...

Central trial contact

Levin Sliker, PhD; Rebecca Connolly

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems